Fluorodopa F 18
Chemical Name | Fluorodopa F 18 |
Dosage Form | Injectable (intravenous; 15.5 MBq/mL to 308.2 MBq/mL (0.42 mCi/mL to 8.33 mCi/mL)) |
Drug Class | Radioactive diagnostic agents |
System | Nervous |
Company | Feinstein |
Approval Year | 2019 |
Indication
- Fluorodopa F 18 is indicated for use in positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes (PS). Fluorodopa F 18 PET is an adjunct to other diagnostic evaluations.